Most Viewed Glioblastoma Current Events | Glioblastoma News
|
|
|
Sort By:
Relevance | Date |
Killing brain tumors from within: A 'Trojan horse' approach
A new method for targeting malignant brain tumors through inducing the cancerous cells to "commit suicide" has been developed by a team of researchers headed by a Hebrew University of Jerusalem professor of biochemistry. view more (2006-10-25)
Researchers identify target for therapeutic drugs to fight most common adult brain cancer
A research team at UT Southwestern Medical Center has discovered a cell-signaling mechanism instrumental in the most common brain cancer in adults. view more (2006-01-16)
NIH researchers identify key factor that stimulates brain cancer cells to spread
Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM). view more (2009-08-19)
Cedars-Sinai researchers discover treatment for deadly brain tumors and infections
In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain... view more... (2006-03-27)
Hopkins geneticist discovers mutations in cancer cells that suggest new forms of treatment
Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors, a discovery that could pave the way for more effective cancer treatments. view more (2005-09-27)
Researchers at Vanderbilt-Ingram Cancer Center uncover clue to explain invasive brain tumors
Researchers at the Vanderbilt-Ingram Cancer Center have uncovered a clue to explain the invasive nature of an aggressive kind of brain tumor called glioblastoma multiforme, or gliomas. view more (2006-01-12)
Natural protein stops deadly human brain cancer in mice
Scientists from Johns Hopkins and from the University of Milan have effectively proven that they can inhibit lethal human brain cancers in mice using a protein that selectively induces positive changes in the activity of cells that behave like cancer stem cells. view more (2006-12-08)
Cancer stem cells linked to radiation resistance
Certain types of brain cancer cells, called cancer stem cells, help brain tumors to buffer themselves against radiation treatment by activating a "repair switch" that enables them to continue to grow unchecked. view more (2006-10-19)
Genetic analysis of glioblastoma brain tumors can aid in treatment decisions, study shows
Screening glioblastoma brain tumors for two gene variations can reliably predict which tumors will respond to a specific class of drugs, a new study shows. view more (2005-11-10)
Clinical trial evaluating brain cancer vaccine is underway at NYU
A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. view more (2007-10-22)
An excellent response to BNCT treatment in head and neck cancer
A Finnish research group has been the first in the world to publish an article in which BNCT treatment has had an excellent response in a patient with head and neck cancer for whom there was no other treatment available. The case report has been published in the June issue of the prestigious Radiotherapy and Oncology no. 72 (2004) pp. 83 - 84. view more (2004-09-14)
Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
Mayo Clinic Cancer Center has opened a new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme, a largely untreatable brain tumor. This is the second of several pending molecular medicine studies in patients using measles to kill cancer. view more (2006-10-31)
UCLA discovery will aid in treatment of patients with a deadly brain cancer
Researchers at UCLA's Jonsson Cancer have identified key characteristics in certain deadly brain tumors that make them 51 times more likely to respond to a specific class of drugs than tumors in which the molecular signature is absent. view more (2005-11-10)
UC Davis researchers find molecule that targets brain tumors
UC Davis Cancer Center researchers report today the discovery of a molecule that targets glioblastoma, a highly deadly form of cancer. The finding, which is published in the January 2009 issue of the European Journal of Nuclear Medicine and Molecular Imaging, provides hope for effectively treating an incurable cancer. view more (2008-12-30)
New angiogenesis inhibitor has promise for treating deadly brain tumor
Researchers from the Massachusetts General Hospital (MGH) Cancer Center have found that AZD2171 (RECENTIN(tm)), a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. view more (2007-01-17)
Drug combination might offer hope for patients deadly brain tumors
Brain cancer patients with the poorest prognosis -- those with a type of deadly tumor known as glioblastoma multiforme (GBM) -- may survive longer with a drug that chokes off a tumor's blood supply. view more (2007-10-19)
Radiotherapy advance points way to noninvasive brain cancer treatment
With an equal rate of incidence and mortality-the number of those who get it, and the number of those who die from it-Glioblastoma Multiforme (GBM) is a brain cancer death sentence. view more (2006-01-03)
Investigating the measles virus as a tool to kill multiple myeloma
Mayo Clinic Cancer Center has opened a new Phase I clinical trial testing an engineered measles virus against multiple myeloma, a cancer of the bone marrow that currently has no cure. This is the third of a series of molecular medicine studies in patients testing the potential of measles to kill cancer. view more (2007-03-06)
Common Virus May Help Doctors Treat Deadly Brain Tumors
A common human virus may prove useful in attacking the deadliest form of brain tumors, according to study conducted by researchers at Duke's Preston Robert Tisch Brain Tumor Center. view more (2007-10-23)
Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
While new blood vessel growth from preexisting capillaries ("angiogenesis") is fundamental to survival, the abnormal formation of new blood vessels ("neovascularization") contributes to the pathogenesis of tumor growth and metastasis as well as the vast majority of diseases that lead to catastrophic loss of vision. view more (2007-01-11)
|
|
|
|
Sort By:
Relevance | Date |
|
